Medica RCP |Gemcitabine Hospira 2g* | Indications | Side Effects | Composition | Route | all.price

Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Gemcitabine Hospira 2g*

Contraindicated
Reproductive toxicity in animals

Contraindicated

Gemcitabine Hospira 2g* :
Type	Medicine Non Marketed
Originator	G
Agent	Food & Drug Corporation
Distributor	Food & Drug Corporation
Laboratory	Hospira
Responsible Party	Hospira UK Ltd
Origin	UK
Manufacturer	Hospira UK Limited
Manufacturing Type	G
Origin	UK
ATC	L01BC05

Gemcitabine Hospira 2g* :

Injectable

Intravenous

Gemcitabine Hospira 2g* :

L Antineoplastic and immunomodulating agents

L01 Antineoplastic agents

L01B Antimetabolites

L01BC Pyrimidine analogues

L01BC05 Gemcitabine

Gemcitabine Hospira 2g* :

Gemcitabine : 2g

Gemcitabine Hospira 2g* :

Adults : Adenocarcinoma pancreas 1000mg/m², once a week for 7 weeks

Adults : Bladder Neoplasm 1000mg/m² on days 1, 8 and 15, for a 28-day cycle

Adults : Metastatic breast cancer 1250mg/m² on Days 1 and 8 of each 21-day cycle

Adults : Non-small cell lung cancer 1000mg/m², once a week for 3 weeks

Gemcitabine Hospira 2g* :

Hydrochloric acid (E507)

Mannitol (E421)* Digestive disorders

Povidone 30

Sodium acetate

* Excipient with known effect

Hazard Level
◼ Major
◼ Moderate
◼ Minor
◼ Safe

Gemcitabine Hospira 2g* :

Revision Date :

Frequency	Percentage
Very Common	≥ 1/10
Common	≥ 1/100 - < 1/10
Uncommon	≥ 1/1,000 - < 1/100
Rare	≥ 1/10,000 - < 1/1,000
Very Rare	< 1/10,000
Unknown	Cannot be Estimated

Effect	Frequency
Alopecia	Very Common
ALT increased	Very Common
Anaemia	Very Common
Anaphylactoid reactions	Very rare
Anorexia	Common
Arrhythmia	Uncommon
Arrhythmia supraventricular	Uncommon
AST increased	Very Common
Asthenia	Common
Back pain	Common
Blisters (Vesicle)	Rare
Blood bilirubin increased	Common
Bronchospasm	Uncommon
Bullous eruption	Rare
Cardiac failure	Uncommon
Cephalea	Common
Cerebrovascular accident	Uncommon
Chills	Common
Colitis ischaemic	Very rare
Constipation	Common
Cough	Common
Death	Uncommon
Desquamation	Rare
Diarrhoea (Diarrhea)	Common
Dyspnoea (dyspnea)	Very Common
Face oedema	Very Common
Febrile neutropenia (Neutropenic fever)	Common
Fever	Common
Gamma-GT increased	Rare
Gangrene	Rare
Haematuria (Hematuria)	Very Common
Haemolytic uraemic syndrome (HUS)	Uncommon
Hepatic failure (Hepatic insufficiency) (Liver failure)	Uncommon
Hepatotoxicity (liver toxicity)	Uncommon
Hypotension	Rare
Influenza symptoms	Very Common
Injection site reaction	Rare
Insomnia	Common
Interstitial pneumonitis	Uncommon
Leucopenia (Leukopenia)	Very Common
Lyell Syndrome (Toxic epidermal necrolysis)	Very rare
Mouth ulceration	Common
Myalgia	Common
Myocardial infarction	Rare
Nausea	Very Common
Neutropenia	Very Common
Oedema	Very Common
Oedema peripheral	Very Common
Peripheral vasodilatation (Peripheral vasculitis)	Rare
Platelet count decreased (Thrombocyte count decreased)	Very Common
Proteinuria	Very Common
Pruritus	Very Common
Pulmonary oedema	Rare
Radiation recall syndrome	Rare
Radiation toxicity	Rare
Renal insufficiency	Uncommon
Respiratory distress syndrome	Rare
Rhinitis	Common
Skin Eruption	Very Common
Skin ulcer	Rare
Somnolence	Common
Stevens-Johnson syndrome	Very rare
Stomatitis	Common
Sweating	Common
Thrombocythaemia	Very rare
Vomiting	Very Common

Gemcitabine Hospira 2g* :

Abu Dhabi

Belgium

Cyprus

Czech Republic

Denmark

Finland

France

Iceland

Italy

Norway

Oman

Spain

The Netherlands

UAE

Form	Powder for solution for infusion
Packaging	Bottle
Package Size	1x52.6ml
Strength	2g
NSSF	✘
Quarantine	✘
Reg. Number	166923/11
Submission date	01/01/2011
Registration Year	2011
Archived Date	2019

TAU

Abraxane²

Benta Trading Co

Celgene

Medicine Authorised

Abraxane²

Droguerie de l'Union

BMS

Medicine Authorised

Adenex SV 120mg

Macromed

Fresenius Kabi Oncology

Medicine Authorised

Adenex SV 20mg

Macromed

Fresenius Kabi Oncology

Medicine Authorised

Adenex SV 80mg

Macromed

Fresenius Kabi Oncology

Medicine Authorised

Alimta 100mg

Droguerie de l'Union

Lilly

Medicine Authorised

Alimta 100mg²

Droguerie de l'Union

Lilly

Medicine Authorised

Alimta 500mg

Droguerie de l'Union

Lilly

Medicine Authorised

Alimta 500mg²

Droguerie de l'Union

Lilly

Medicine Authorised

Anzatax 150mg

Food & Drug Corporation

Pfizer

Medicine Authorised

Anzatax 300mg

Food & Drug Corporation

Pfizer

Medicine Authorised

Anzatax 30mg

Food & Drug Corporation

Pfizer

Medicine Authorised

Aryotrust 150mg

Lebiran

Aryogen

Medicine Authorised

Aryotrust 440mg

Lebiran

Aryogen

Medicine Authorised

Avastin 100mg

Omnipharma

Roche

Medicine Authorised

Avastin 100mg²

Omnipharma

Roche

Medicine Authorised

Avastin 400mg

Omnipharma

Roche

Medicine Authorised

Avastin 400mg²

Omnipharma

Roche

Medicine Authorised

Bevacirel 100mg

Levant Pulse

Reliance Life Sciences

Medicine Authorised

Bevacirel 400mg

Levant Pulse

Reliance Life Sciences